StockNews.com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ:ONCT opened at $0.53 on Wednesday. Oncternal Therapeutics has a 12 month low of $0.53 and a 12 month […]
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ:ONCT opened at $0.53 on Wednesday. Oncternal Therapeutics has a 12 month low of $0.53 and a 12 month […]
